Development and characterization of nano-emulsification and liposomal platforms (NEP and LIP) for hemp oil nanoencapsulation and transmucosal delivery
A novel technology for delivery of biologically active compounds found in hemp oil is being developed. This novel technology significantly reduces the health risks associated with traditional administration of Cannabis products (e.g., smoking and THC-related intoxication) The proposed project, in collaboration with a federally-licensed facility for cannabinoid analysis, Abattis Bioceuticals, engages into the development of two different platforms for encapsulation of hemp oil using nanoemulsion and nanolipid carrier technologies. Two interns will be trained on different technologies related to the encapsulation of hemp oil and evaluation of in-vitro bioavailability. By the end of this project, an optimized delivery platform will be available for further in-vivo testing and clinical trials for oral delivery of CBD and other cannabinoids and terpenes. Abattis Bioceuticals expects to employ the developed technology for exploring new avenues for the safe and efficient manufacture of commercial and medical applications.